Works from 2025
An invisible flare: Isolated gastrointestinal symptoms in Type 1 hereditary angioedema: A5534, Manuel Villegas Roberson, Vaidehi H. Joshi, P Kuprien, et al. (Abstract)
Finding the castle: Diagnosing castleman syndrome in healthy pediatric female: A6556, Samrita Sawhney and Clifford Klimas (Abstract)
Effect of intravenous immunoglobulin (IVIG) supplementation on infection-free survival in recipients of BCMA-directed bispecific antibody therapy for multiple myeloma, Meera Mohan, Aniko Szabo, Heloise Cheruvalath, et al. (Article)
5-Methylcytosine profiles in circulating cell-free DNA in peanut allergy, So Lim Kim, Jamel Mansur, Toni Ramirez, et al. (Abstract)
Stress-induced changes in immune signatures in ME/CFS patients determined by transcriptome analysis, Jackson Gamer, Derek Van Booven, Oskar Zarnowski, et al. (Book Chapter)
Works from 2024
Break through the mold: Hyper-IgE syndrome as a vehicle for invasive aspergillosis, Joseph Nordin, Stephen Smetana, Rachel Johnson, et al. (Article)
Trusted sources of information and COVID-19 vaccination among Black adults in Chicago, Jana L. Hirschtick, Jennifer L. Walsh, Wayne DiFranceisco, et al. (Article)
Sarcoidosis-lymphoma syndrome and CVID: Finding the zebra and overcoming health disparity barriers, Emma C. Williams and Andrea A. Pappalardo (Article)
Real-world outcomes with immuno-oncology therapies in advanced melanoma: Final results of the OPTIMIzE registry study, John M. Kirkwood, Lisa A. Kottschade, Robert R. McWilliams, et al. (Article)
Works from 2023
Adding tiotropium or long-acting β2-agonists to inhaled corticosteroids: Asthma-related exacerbation risk and healthcare resource utilization, Nicola A. Hanania, Russell A. Settipane, Samir Khoury, et al. (Article)
Long-term efficacy and safety of Upadacitinib in patients with rheumatoid arthritis: Final results from the BALANCE-EXTEND Open-Label Extension Study, Alan Kivitz, Alvin F. Wells, Juan I. Vargas, et al. (Article)
A Case Report of Amiodarone-Induced Thyrotoxicosis Requiring Plasmapheresis as a Bridge to Total Thyroidectomy, Tina Moazezi and Chung-Kay Koh (Poster)
A Unique Case of Immunotherapy Related Autoimmune Complications, Hardeep S. Ahdi, Edward Nabrinsky, and Sufyan Abdulmujeeb (Poster)
Proposed solutions by the American College of Allergy, Asthma, and Immunology and advocacy experts to address racial disparities in atopic dermatitis and food allergy, Mark Corbett, Abby Allen, Nichole Bobo, et al. (Article)
Asthma morbidity measures across Black ethnic subgroups, Leah Ishmael, Juan Carlos Cardet, Michael Foggs, et al. (Abstract)
Interplay of immunosuppression and immunotherapy among patients with cancer and COVID-19, Ziad Bakouny, Chris Labaki, Punita Grover, et al. (Article)
Works from 2022
Human abdominal aortic aneurysm (AAA): Evidence for an autoimmune antigen-driven disease, Song Lu, John V. White, Ifeyinwa Nwaneshiudu, et al. (Article)
Pivotal clinical trial enrollment of Blacks in multiple sclerosis or neuromyelitis spectrum disorder: When will we achieve parity?, Jagannadha Avasarala, Phenu Zachariah, and Breck Turner (Article)
A review of the abscopal effect in the era of immunotherapy, Edward Nabrinsky, Jason Macklis, and Jacob Bitran (Article)
Optimizing asthma management: Role of long-acting muscarinic antagonists, Thomas B. Casale, Michael B. Foggs, and Ronald C. Balkissoon (Article)
Baseline disease activity predicts achievement of cDAPSA treatment targets with apremilast: Phase 3 results in DMARD-naive patients with psoriatic arthritis, Philip J. Mease, Arthur Kavanaugh, Alexis Ogdie, et al. (Article)
The role of physician advocacy in achieving health equity: Where is the allergist-immunologist?, Margee Louisias, Roselyn Hicks, Samantha Jacobs, et al. (Article)
Apremilast monotherapy for long-term treatment of active psoriatic arthritis in DMARD-naive patients, Alvin F. Wells, Christopher J Edwards, Alan J Kivitz, et al. (Article)
Lymphadenopathy, Sarah Burroughs and Evan Kang (Book Chapter)
Works from 2021
Myasthenia gravis induced or exacerbated by immune checkpoint inhibitors: a rising concern, Behnam Hajihossainlou, Alisa Vasileva, Sukesh Manthri, et al. (Article)
Efficacy of long-term treatment with once-daily baricitinib 2 mg in patients with active rheumatoid arthritis: Post hoc analysis of two 24-week, phase III, randomized, controlled studies and one long-term extension study, Alvin F. Wells, Bochao Jia, Li Xie, et al. (Article)
Leveraging Human Genetic Variation to Uncover the Molecular Basis of T Cell Selection and Autoimmunity, Caroline Kaiser, Narutoshi Hibino, Emily Pena, and Andrew Koh (Poster)
Health disparities in allergic and immunologic conditions in racial and ethnic underserved populations: A work group report of the AAAAI committee on the underserved., Carla M Davis, Andrea J Apter, Adrian Casillas, et al. (Article)
Works from 2020
Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPY, Vibeke Strand, Namita Tundia, Alvin Wells, et al. (Article)
How does stellate ganglion block alleviate immunologically-linked disorders?, Eugene Lipov, Vicko Gluncic, Ivan K Lukić, et al. (Article)
Reasons for hospitalization and in-hospital mortality in adult systemic lupus erythematosus, Augustine M Manadan, Soumyasri Kambhatla, Estefania Gauto-Mariotti, et al. (Article)
Work Group Report: COVID-19: Unmasking Telemedicine, Nathan Hare, Priya Bansal, Sakina S Bajowala, et al. (Article)
Works from 2019
Assessment of citations of the retracted article by Wakefield et al with fraudulent claims of an association between vaccination and autism, Elizabeth M. Suelzer, Jennifer Deal, Karen L. Hanus, et al. (Article)
Works from 2016
Differential effects of alternative glycoforms of IgG on human monocytes and macrophages: sialylated IgG induces novel expression signatures of cell surface markers, cytokines, and chemokines, Eric D. Bruder, John O. Richards, Karen M. Michel, et al. (Article)
Works from 2006
A mechanistic study of immune system activation by fusion of antigens with the ligand-binding domain of CTLA4, Dhanalakshmi Chinnasamy, Matt Tector, Nachimuthu Chinnasamy, et al. (Article)
Effect of targeting BTLA-HVEM co-inhibitory pathway in partial MHC-mismatched cardiac grafts, V Vadivel, J Yang, V K. Vanguri, et al. (Abstract)
Works from 2005
Association of the CTLA-4 gene with rheumatoid arthritis in Chinese Han population, Cai Lei, Zhang Dongqing, Shi Yeqing, et al. (Article)
Expression of FOX-P3, GATA-3, and GITR during tolerance and breaking of tolerance: Abstract #221., Willem-jan Flu, Anna-Maria Wagga, Volkert Huurman, et al. (Abstract)
CTLA-4 is important in maintaining long-term survival of cardiac allografts, Anil Chandraker, Volkert Huurman, Karen Hallett, et al. (Article)
Ex vivo generation of genetically modified dendritic cells for immunotherapy: implications of lymphocyte contamination, Nachimuthu Chinnasamy, Martin Oaks, J S. Treisman, et al. (Article)
Works from 2003
A novel monoclonal anti-rat CTLA4 antibody abrogates longterm cardiac allograft survival induced by anti-CD28/CSA, Xueli Yuan, Volkert Huurman, Alan D. Salama, et al. (Abstract)
Alloimmune induction of endothelial cell-derived interferon-gamma-inducible chemokines, Raghavanpillai Raju, Angela Malloy, Tara Shah, et al. (Article)
Works from 2000
Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease, Martin Oaks and Karen M. Hallett (Article)
A native soluble form of CTLA-4, Martin Oaks, Karen Hallett, R T Penwell, et al. (Article)
Works from 1994
Molecular cytogenetic mapping of the human melanoma antigen (MAGE) gene family to chromosome region Xq27-qter: implications for MAGE immunotherapy, Martin K. Oaks, J P Hanson, and D P O'Malley (Article)
Works from 1992
The effect of cimetidine on lymphocyte subpopulations in vivo in experimental mice, A Kumar, Martin K. Oaks, and K J Kelly (Article)